You are here:
Note: Proceeds are funds made available to Gavi from donor contributions and commitments, either through cash payments made to Gavi, through frontloading via the capital markets of a future donor commitment to IFFIm, or through AMC funds released to Gavi via the World Bank. Future IFFIm proceeds from new pledges made at the Berlin pledging conference are indicative and are based on certain assumptions including future interest rates and foreign exchange rates generated from financial market data, and donor payment schedules. These assumptions may differ from conditions prevailing at the time of grant and legal agreement signing, which may result in different projected and realised IFFIm proceeds.
Click on Direct, IFFIm, AMC or Matching Fund in the above key to toggle their data on the graph, click again to show the data
Notes:Direct Contributions (including Matching Fund)Received contributions: non-US$ contributions for 2000-2016 are expressed in US$ equivalents using the exchange rates on the dates of receipt. For 2014, 2015 and 2016, where contributions were hedged to mitigate currency risk exposure, these have been expressed using the rates applicable to the hedge agreement.
Future contributions: non-US$ Direct Contribution and Matching Fund pledges for years 2017 and beyond are expressed in US$ equivalents using the applicable 'forecast rates' from Bloomberg as at 31 December 2016 or using the rates applicable to any hedge agreement in place.
IFFIm contributionsReceived contributions: non-US$ contributions for 2000-2016 are expressed in US$ equivalents as confirmed by the IBRD (World Bank)
Future contributions: non-US$ contributions are expressed in US$ equivalents as follows:
Norway is one of the original six donors to Gavi and has steadily increased its strong long-term political and financial support. Norway’s support to Gavi is advocated at the highest level and is anchored in a strong cross-party political understanding of the value of investing in immunisation. Norway has taken a very active role in Gavi and was the co-host, with the USA, of a meeting in New York in October 2010 which opened for the first Gavi pledging conference. Norway is represented on the Gavi Board in the Board Constituency also comprising The Netherlands and Sweden, and currently holds the Board Member seat for the constituency.
Norway contributes to the Vaccine Alliance through three funding channels; Direct, IFFIm and AMC. Since 2001, Norway has contributed USD 1.14 billion to Gavi in direct contributions, USD 50 million to AMC and has committed USD 250 million through IFFIm. Norwegian private sector companies, such as DNB and Statoil, as well as private individuals have also provided funding to Gavi.
At the pledging conference in London in 2011, the Norwegian Prime Minister committed USD 612 million in direct funding for the period 2011-2015, in addition to the existing agreements of USD 50 million to AMC and NOK 1.5 billion (USD 250 million) to IFFIm. In Berlin 2015, the Prime Minister announced a 50% increase in the Norwegian direct support to Gavi for the period 2016-2020, bringing the total future Norwegian contribution up to NOK 6.25 billion.
Additionally, in 2014 Norway committed NOK 1.14 billion (USD 155 million) for the period 2014-2019 to support the Vaccine Alliance’s effort to complement GPEI’s work, strengthening routine immunisation and introducing inactivated polio vaccine (IPV) in Gavi-supported countries.
Contributions and pledges in total:
Gavi Pledging Conference - Berlin, 26-27 January 2015
Norway pledge announcement
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2017
modal window here